top of page

Investors

Rectangle 176.png

>€10B

Total adressable market

China

>€3B

23%

Up affected population​

China

16%

Join the forefront of phlebology treatments!

Promising market prospects

  • A huge potential market in Europe : 235m patients

  • Potential for future value creation (~80M€+ projected revenue in 2030)

An exclusive worldwide licence with Inserm

  • Committed founders and a highly qualified and experienced team

  • Six years of research and development in ultrasound technology

An unmet clinical need for a safe, rapid and painless therapy

  • A non-invasive, comfortable approach to meet the needs of patients and doctors

  • A differentiated and validated non-thermal HIFU technology

    • A non-invasive, comfortable approach to meet the needs of patients and doctors

    • A differentiated and validated non-thermal HIFU technology

    • Committed founders and a highly qualified and experienced team

    • Six years of research and development in ultrasound technology​

    • A huge potential market in Europe : 235m patients

    • Potential for future value creation (~80M€+ projected revenue in 2030)

Why invest ?

Outstanding Exits

A dynamic and active acquisition market in the last decade

2009

$440m

Covidien acquired VNUS inc.

2014

$220m

Covidien acquired Sapheon

$660

Merz acquired Ulthera inc.

2021

+$500m

BD acquired Venclose

2009

2014

2021

+$500m

BD acquired Venclose

$660m

Merz acquired Ulthera inc.

$220m

Covidien acquired Sapheon

$440m

Covidien acquired VNUS inc.

Outstanding Exits

A dynamic and active acquisition market in the last decade

A breakthrough technology

COMPANIES

NON-INVASIVE

PAINLESS

FAST

OFFICE-BASED

NON-THERMAL

ULTRASOUND

FOAM

GLUE

Untitled.png

Concurent

Concurent

ULTRASOUND

FOAM

GLUE

THERMAL

THERMAL ABLATION

ULTRASOUND

Concurent

Concurent

News & Press releases

July 00th 2024

Lorem ipsum dolor sit amet consectetur. Massa enim viverra viverra sodales lacus.

Lorem ipsum dolor sit amet consectetur. Massa enim viverra viverra sodales lacus. Interdum tristique cursus scelerisque donec mi nunc quis.

July 00th 2024

Lorem ipsum dolor sit amet consectetur. Massa enim viverra viverra sodales lacus.

Lorem ipsum dolor sit amet consectetur. Massa enim viverra viverra sodales lacus. Interdum tristique cursus scelerisque donec mi nunc quis.

picture-article-veinsound-non-invasive-treatment-of-varicose-veins.png

July 7, 2025

Non-invasive treatment of varicose veins: Veinsound will change the game!

Varicose veins are not just a cosmetic inconvenience. They can also cause heaviness, pain, and in some cases, circulatory complications...

Medinov.jpg

July 7, 2025

Non-invasive treatment of varicose veins: Veinsound will change the game!

Varicose veins are not just a cosmetic inconvenience. They can also cause heaviness, pain, and in some cases, circulatory complications...

Medinov.jpg

May 19, 2025

🏆 Veinsound wins the Innovation Award at Medi’Nov Connection 2025

At the 13th edition of Medi’Nov Connection, the unmissable annual gathering for MedTech in France, our CEO Thomas Charrel presented the...

Medinov.jpg

April 28, 2025

Polytechnique Alumni - Thomas Charrel CEO de Veinsound

Paris, le 28 avril 2025   Veinsound : une révolution dans le traitement des varices Veinsound  est une start-up lyonnaise qui développe...

July 00th 2024

Lorem ipsum dolor sit amet consectetur massa enim.

June 00th 2024

Lorem ipsum dolor sit amet consectetur massa enim.

Want to know more about our product ?

Learn more

Contact us to know more about Veinsound

We will answer you as soon as possible

Contact us to know more about Veinsound

We will answer you as soon as possible

bottom of page